Verenigde Arabische Emiraten - Engels - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading india - 30's (10's blister x 3) - tablet - 10 + 10 mg - cardiovascular system-lipid-regulators, cardiovascular system-lipid-regulators

Verenigde Staten - Engels - NLM (National Library of Medicine)

qyk brands llc - vardenafil (unii: uce6f4125h) (vardenafil - unii:uce6f4125h) - vardenafil hydrochloride tablets are indicated for the treatment of erectile dysfunction. administration of v ardenafil hydrochloride tabletswith nitrates (either regularly and/or intermittently) and nitric oxide donors is contraindicated [see clinical pharmacology (12.2)] . consistent with the effects of pde5 inhibition on the nitric oxide/cyclic guanosine monophosphate pathway, pde5 inhibitors, including v ardenafil hydrochloride tablets, may potentiate the hypotensive effects of nitrates. a suitable time interval following dosing of v ardenafil hydrochloride tabletsfor the safe administration of nitrates or nitric oxide donors has not been determined. do not use v ardenafil   hydrochloride tablets in patients who are using a gc stimulator, such as riociguat. pde5 inhibitors, including v ardenafil   hydrochloride tablets may potentiate the hypotensive effects of gc stimulators. pregnancy category b vardenafil is not indi

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - benzoyl peroxide 10% (+ overage of 19.95% =11.995%);  ;  ; benzoyl peroxide 10%{relative} (+ overage of 19.95% =11.995%) - topical gel - 10 % - active: benzoyl peroxide 10% (+ overage of 19.95% =11.995%)     excipient: citric acid monohydrate denatonium benzoate ethanol hypromellose lauromacrogol 200 perfume/fragrance alpine 6565a saponite tert-butyl alcohol water active: benzoyl peroxide 10%{relative} (+ overage of 19.95% =11.995%) excipient: citric acid ethanol hypromellose colloidal aluminium magnesium silicate lauromacrogol 200 perfume/fragrance alpine 6565a water

Filipijnen - Engels - FDA (Food And Drug Administration)

otsuka (phils.) pharmaceutical, inc.; distributor: otsuka (phils.) pharmaceutical, inc. - 10% dextrose in water - solution for iv infusion - 10g/ 100ml (10% w/v)

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - calcium gluconate - solution - 10 %

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - calcium gluconate - solution - 10 %

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose - solution for injection - 10 %

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose - solution for injection - 10 %

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose - solution for injection - 10 %

Saoedi-Arabië - Engels - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose - solution for injection - 10 %